Back to search
FDAFDA · Food and drugs·Recall number D-0802-2022

AT-1, Papaverine 8mg/ml . Phentolamine 2mg/ml . Atropine 0.2mg/ml, Multi-Dose 10 ml vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0039-10

Published May 4, 2022 · Recall initiated: April 4, 2022

Summary

FDA records drug Class II recall D-0802-2022, published May 4, 2022 and initiated April 4, 2022. Recalling firm: Olympia Compounding Pharmacy dba Olympia Pharmacy; Status: Terminated; Reported quantity: 310 vials; Lot: Lots: F41C28 BUD: 6/28/2022, F41B28 BUD: 6/28/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Olympia Compounding Pharmacy dba Olympia Pharmacy
Distributor
Distributed Nationwide in the USA
Lot
Lots: F41C28 BUD: 6/28/2022, F41B28 BUD: 6/28/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was AT-1, Papaverine 8mg/ml . Phentolamine 2mg/ml . Atropine 0.2mg/ml, Multi-Dose 10 ml vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0039-10 recalled?

Yes. FDA published recall D-0802-2022 on May 4, 2022. Reported hazard: CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

What should I do if I have this product?

Voluntary: Firm initiated · Letter